Literature DB >> 21529980

A structured tool to analyse coverage decisions: development and feasibility test in the field of cancer screening and prevention.

Katharina E Fischer1, Reiner Leidl, Wolf H Rogowski.   

Abstract

OBJECTIVES: The comparison of fourth hurdle processes is challenging because they are heterogeneous and decision practice may deviate from formal process rules. This study applies a published framework consisting of key steps of coverage decision processes to the area of cancer prevention.
METHODS: A research design was developed for analysis of case studies on past decision processes. Decisions were identified and information on the process steps was elicited by semi-structured telephone interviews with decision-makers and experts. The scheme was validated with experts from the areas of screening and prevention and fourth hurdle decision making.
RESULTS: Indicators for a structured empirical comparison of coverage decisions were derived. Corresponding ordinal rankings were proposed. Details on six decisions about cancer screening (colorectal and prostate cancer) and vaccination against human papillomavirus in Sweden, Austria and Lithuania are presented.
CONCLUSIONS: The development of the structured scheme for analysis of coverage decisions allows validation of official statements on decision processes and collection of larger data sets for empirical analysis. However, the semi-structured phone interviews were time-consuming for collecting information on a larger number of decisions. Further validation of the structured scheme and development of a research tool for large-scale empirical studies is still needed.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21529980     DOI: 10.1016/j.healthpol.2011.03.002

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  5 in total

1.  Analysing coverage decision-making: opening Pandora's box?

Authors:  Katharina Elisabeth Fischer; Reiner Leidl
Journal:  Eur J Health Econ       Date:  2014-02-06

Review 2.  Funding decisions for newborn screening: a comparative review of 22 decision processes in Europe.

Authors:  Katharina Elisabeth Fischer; Wolf Henning Rogowski
Journal:  Int J Environ Res Public Health       Date:  2014-05-19       Impact factor: 3.390

Review 3.  Evaluating Quality of Decision-Making Processes in Medicines' Development, Regulatory Review, and Health Technology Assessment: A Systematic Review of the Literature.

Authors:  Magdalena Bujar; Neil McAuslane; Stuart R Walker; Sam Salek
Journal:  Front Pharmacol       Date:  2017-04-10       Impact factor: 5.810

4.  Decision-making in healthcare: a practical application of partial least square path modelling to coverage of newborn screening programmes.

Authors:  Katharina E Fischer
Journal:  BMC Med Inform Decis Mak       Date:  2012-08-02       Impact factor: 2.796

5.  Reimbursement of orphan drugs in Belgium: what (else) matters?

Authors:  Eline Picavet; David Cassiman; Steven Simoens
Journal:  Orphanet J Rare Dis       Date:  2014-09-12       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.